OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells presents a paramount challenge with the biopharmaceutical industry. Various strategies have been employed to antibody titer, such as process parameter optimization, genetic engineering, and implementation of perfusion technologies. Fine-tuning growth parame